COPD is a progressive, irreversible inflammatory disease of the lungs that makes it difficult to breathe. Cigarette smoking is the most common cause of COPD. Common symptoms include a persistent cough ...

Conclusion: Tiotropium appears to be at least as effective as currently available alternatives in the treatment of patients with COPD who require daily bronchodilator treatment. Its simplified ...

Tiotropium (Spiriva Respimat) and olodaterol (Striverdi ... dose into the device compared to other devices. Read more about COPD drugs and inhalers for COPD. When used correctly, inhalers can ...

Boehringer’s lung drug Spiriva, approved for chronic obstructive pulmonary disease (COPD) and asthma, generated net sales of 2.4 billion euros, down 11.4% compared with last year, which the ...

You may consider a type of nebulizer for your COPD treatment. These small devices convert medications into mist, allowing you to breathe them in more easily through a mask or machine. The most ...

Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that obstructs airflow and makes breathing difficult. It encompasses several respiratory conditions, including chronic ...

You must go to a doctor to know for sure whether you have COPD. That’s because there are things to consider for a diagnosis. Some people have asthma and COPD at the same time. If you have ...

Ginger, echinacea, and curcumin are just a few of the herbs that you may hear about when looking into natural remedies for chronic obstructive pulmonary disease (COPD) or other respiratory conditions.

1 Department of Pulmonary Medicine, University Medical Centre Groningen, University of Groningen, The Netherlands: University Medical Centre Groningen, Department of Pulmonary Medicine ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these ...

A new study suggests COPD patients experience improved lung ... Boehringer Ingelheim’s Spiriva and AstraZeneca’s Symbicort. Its biggest competitor is GSK, which also has a new dual ...